Equities

YSP Southeast Asia Holding Bhd

YSPSAH:KLS

YSP Southeast Asia Holding Bhd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MYR)2.98
  • Today's Change0.01 / 0.34%
  • Shares traded76.80k
  • 1 Year change+16.86%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.

  • Revenue in MYR (TTM)368.04m
  • Net income in MYR40.33m
  • Incorporated2001
  • Employees519.00
  • Location
    YSP Southeast Asia Holding Bhd16th Floor, Plaza VADSNo. 1, Jalan Tun Mohd FuadTaman Tun Dr. IsmailKUALA LUMPUR 60000MalaysiaMYS
  • Phone+60 377276390
  • Fax+60 377276701
  • Websitehttps://www.yspsah.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Albert David Ltd204.74m42.60m415.20m1.27k9.751.928.942.03132.16132.16635.16671.050.78682.6712.15--16.3710.0020.8513.1565.3061.0320.8111.873.31124.700.008612.896.122.72108.4933.5940.8713.90
Vita Life Sciences Limited231.54m28.35m422.61m124.0014.463.1214.111.830.1660.1661.360.76951.332.347.35--16.2715.2522.5121.9958.1460.9012.2411.712.29--0.008939.0510.8812.5028.1830.0712.1519.14
YSP Southeast Asia Holding Bhd368.04m40.33m422.70m519.0010.481.037.451.150.28440.28442.602.880.71541.674.53--7.955.839.416.8343.9942.5711.128.463.2989.200.108839.476.214.228.274.224.292.71
Lee's Pharmaceutical Holdings Ltd636.28m10.09m426.95m1.06k42.310.34664.530.6710.02840.02841.793.460.37131.8310.75996,247.900.703313.330.8817.7652.3561.921.8936.200.55263.900.09433.59-14.61-1.53-67.44-47.49-12.19-31.34
Nectar Lifesciences Ltd952.14m2.82m427.53m1.59k146.740.707911.520.4490.230.2379.1647.680.76971.745.12--0.228-0.29560.3969-0.54128.6818.390.2963-0.40520.59071.060.3728--10.63-9.54120.65-36.29-5.06--
Dali Pharmaceutical Co Ltd42.74m-14.87m430.14m272.00--1.76--10.06-0.104-0.1040.29911.710.13811.1515.89241,555.10-4.80-2.31-5.61-2.7722.1665.39-34.78-7.003.11--0.0593---34.06-26.30-13.16--16.34--
Data as of Jun 14 2024. Currency figures normalised to YSP Southeast Asia Holding Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.